Literature DB >> 21160904

Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.

Vincenzo Cardinale1, Rossella Semeraro, Alessia Torrice, Manuela Gatto, Cristina Napoli, Maria Consiglia Bragazzi, Raffaele Gentile, Domenico Alvaro.   

Abstract

Cholangiocarcinoma (CCA) is a malignant tumour that arises from biliary epithelium at any portion of the biliary tree. CCA is currently classified as intra-hepatic or extra-hepatic CCA (EH-CCA). Recent evidences suggest that intra-hepatic CCA (IH-CCA) and EH-CCA are biologically different cancers, giving further support to a number of recent epidemiological studies showing large differences in terms of incidence, mortality and risk factors. The purpose of this manuscript is to review recent literature dealing with the descriptive epidemiology and risk factors of CCA with a special effort to compare IH- with EH-CCA.

Entities:  

Keywords:  Epidemiology; Extra-hepatic cholangiocarcinoma; Intra-hepatic cholangiocarcinoma; Liver cirrhosis; Liver flukes; Liver stem cells; Peribiliary glands; Primary sclerosing cholangitis; Risk factors; Viral hepatitis

Year:  2010        PMID： 21160904      PMCID： PMC3000454          DOI： 10.4251/wjgo.v2.i11.407

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  78 in total

1.  High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation.

Authors:  Stefano Ginanni Corradini; Fausta Micheletta; Silvia Natoli; Massimo Iappelli; Emanuele Di Angelantonio; Rosanna De Marco; Walter Elisei; Maria Siciliano; Massimo Rossi; Pasquale Berloco; Adolfo Francesco Attili; Ulf Diczfalusy; Luigi Iuliano
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

2.  Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features.

Authors:  Y Fukukura; J Taguchi; O Nakashima; Y Wada; M Kojiro
Journal:  J Comput Assist Tomogr       Date:  1997 Jan-Feb       Impact factor: 1.826

3.  Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.

Authors:  G M McQuillan; P J Coleman; D Kruszon-Moran; L A Moyer; S B Lambert; H S Margolis
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

4.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

Authors:  Yan-Ming Zhou; Zheng-Feng Yin; Jia-Mei Yang; Bin Li; Wen-Yu Shao; Feng Xu; Yu-Lan Wang; Dian-Qi Li
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

5.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

6.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

7.  Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003.

Authors:  Rune Erichsen; Peter Jepsen; Hendrik Vilstrup; Anders Ekbom; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2009-06-26       Impact factor: 8.082

8.  A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China.

Authors:  J Shi; L Zhu; S Liu; W-F Xie
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

9.  The antecedents of biliary cancer: a primary care case-control study in the United Kingdom.

Authors:  M J Grainge; J West; M Solaymani-Dodaran; G P Aithal; T R Card
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

10.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307
View more
  62 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

2.  Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages.

Authors:  Guido Carpino; Vincenzo Cardinale; Paolo Onori; Antonio Franchitto; Pasquale Bartolomeo Berloco; Massimo Rossi; Yunfang Wang; Rossella Semeraro; Maurizio Anceschi; Roberto Brunelli; Domenico Alvaro; Lola M Reid; Eugenio Gaudio
Journal:  J Anat       Date:  2011-12-05       Impact factor: 2.610

3.  Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.

Authors:  Vincenzo Cardinale; Guido Carpino; Lola Reid; Eugenio Gaudio; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

4.  Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.

Authors:  Rihyeon Kim; Jeong Min Lee; Cheong-Il Shin; Eun Sun Lee; Jeong Hee Yoon; Ijin Joo; Seong Ho Kim; Inpyeong Hwang; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

5.  Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.

Authors:  Ekaterina Petrova; Felix Rückert; Sebastian Zach; YinFeng Shen; Jürgen Weitz; Robert Grützmann; Uwe A Wittel; Frank Makowiec; Ulrich T Hopt; Peter Bronsert; Florian Kühn; Bettina M Rau; Roman E Izrailov; Igor E Khatkov; Hryhoriy Lapshyn; Louisa Bolm; Dirk Bausch; Tobias Keck; Ulrich F Wellner; Gabriel Seifert
Journal:  Langenbecks Arch Surg       Date:  2017-06-13       Impact factor: 3.445

6.  The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.

Authors:  Xiangguo Tian; Qizhi Wang; Yan Li; Jinhua Hu; Lei Wu; Qian Ding; Chunqing Zhang
Journal:  Pathol Oncol Res       Date:  2014-07-02       Impact factor: 3.201

7.  Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.

Authors:  Juan Putra; Francine B de Abreu; Jason D Peterson; J Marc Pipas; Kabir Mody; Christopher I Amos; Gregory J Tsongalis; Arief A Suriawinata
Journal:  Exp Mol Pathol       Date:  2015-07-17       Impact factor: 3.362

Review 8.  Cholangiocarcinoma presenting as Sister Mary Joseph's nodule: case report and short review of the literature.

Authors:  M C Reichert; G Farmakis; R M Bohle; F Lammert; V Zimmer
Journal:  J Gastrointest Cancer       Date:  2014-06

Review 9.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 10.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.